Validity and reliability of the Turkish version of the central sensitization inventory
The aim of this study was to translate the Central Sensitization Inventory (CSI) into the Turkish language, to perform a psychometric validation, and to investigate its reliability in patients with chronic spinal pain with an organic origin, patients with fibromyalgia, and pain-free control individu...
Gespeichert in:
Veröffentlicht in: | Archives of rheumatology 2021-12, Vol.36 (4), p.518-526 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 526 |
---|---|
container_issue | 4 |
container_start_page | 518 |
container_title | Archives of rheumatology |
container_volume | 36 |
creator | Düzce Keleş, Ela Birtane, Murat Ekuklu, Galip Kılınçer, Cumhur Çalıyurt, Okan Taştekin, Nurettin Is, Enes Efe Ketenci, Ayşegül Neblett, Randy |
description | The aim of this study was to translate the Central Sensitization Inventory (CSI) into the Turkish language, to perform a psychometric validation, and to investigate its reliability in patients with chronic spinal pain with an organic origin, patients with fibromyalgia, and pain-free control individuals.
Between April 2016 and February 2017, the translation of the original English version of the CSI into Turkish was performed using the forward-backward translation method. A total of 100 fibromyalgia patients (6 males, 94 females; mean age: 45.0±8.4 years; range, 25 to 60 years), 100 patients with chronic spinal pain with an identified organic origin (CSPO), (10 males, 90 females; mean age: 43.8±9.7 years; range, 21 to 60 years), and 100 healthy controls (8 males, 92 females; mean age: 35.8±10.1 years; range, 25 to 55 years) were included in the study. Demographic characteristics were collected. Test-retest reliability was determined by re-administering the CSI-Turkish (CSI-Turk) two weeks after the first application.
The internal consistency (Cronbach's alpha) was found to be 0.92 and the intraclass correlation coefficient was 0.93. Patients with fibromyalgia, a very common central sensitivity syndrome (CSS), had the highest mean CSI-Turk scores, and healthy controls had the lowest. Using the recommended cut-off score of 40 resulted in 87% sensitivity and 90% specificity in distinguishing between fibromyalgia and control individuals.
This study suggests that the CSI-Turk can be effectively used as a screening tool to elucidate CS-related symptomology among patients with chronic pain with a high internal consistency, test-retest reliability, sensitivity, and specificity. |
doi_str_mv | 10.46497/ArchRheumatol.2022.8665 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8957757</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A688976788</galeid><sourcerecordid>A688976788</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2965-8f4a65d096638355becb71f60d36d6a9d5e900bb76bb84581df77204c3b645b83</originalsourceid><addsrcrecordid>eNpVkV1LwzAUhoMobsz9BemVd51pk5ykN8IYfsFAkLnbkLTpGs3akXSD-ett3Rzu6ny_5xwehKIETyjQjN9PfV69V2a7Vm3jJilO04kAYBdomEIiYmAYX3Z-QkXMMIUBGofwiTFOKAfA5BoNCCMiJTwZouVSOVvYdh-puoi8cVZp6_q4KaO2MtFi679sqKKd8cE29V86N3XrlYuCqYNt7bdq-6Ktd12-8fsbdFUqF8z4aEfo4-lxMXuJ52_Pr7PpPM7TDFgsSqqAFTgDIIIwpk2ueVICLggUoLKCmQxjrTloLSgTSVFynmKaEw2UaUFG6OGgu9nqtSmOV8mNt2vl97JRVp5XalvJVbOTImOcM94J3B0EVsoZWRnl2io0btu_E-QUhMg4cNFvEofG3DcheFOeliRY_nKRZ1xkz0X2XLrR2_9Hngb_KJAfE_qPXw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Validity and reliability of the Turkish version of the central sensitization inventory</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Düzce Keleş, Ela ; Birtane, Murat ; Ekuklu, Galip ; Kılınçer, Cumhur ; Çalıyurt, Okan ; Taştekin, Nurettin ; Is, Enes Efe ; Ketenci, Ayşegül ; Neblett, Randy</creator><creatorcontrib>Düzce Keleş, Ela ; Birtane, Murat ; Ekuklu, Galip ; Kılınçer, Cumhur ; Çalıyurt, Okan ; Taştekin, Nurettin ; Is, Enes Efe ; Ketenci, Ayşegül ; Neblett, Randy</creatorcontrib><description>The aim of this study was to translate the Central Sensitization Inventory (CSI) into the Turkish language, to perform a psychometric validation, and to investigate its reliability in patients with chronic spinal pain with an organic origin, patients with fibromyalgia, and pain-free control individuals.
Between April 2016 and February 2017, the translation of the original English version of the CSI into Turkish was performed using the forward-backward translation method. A total of 100 fibromyalgia patients (6 males, 94 females; mean age: 45.0±8.4 years; range, 25 to 60 years), 100 patients with chronic spinal pain with an identified organic origin (CSPO), (10 males, 90 females; mean age: 43.8±9.7 years; range, 21 to 60 years), and 100 healthy controls (8 males, 92 females; mean age: 35.8±10.1 years; range, 25 to 55 years) were included in the study. Demographic characteristics were collected. Test-retest reliability was determined by re-administering the CSI-Turkish (CSI-Turk) two weeks after the first application.
The internal consistency (Cronbach's alpha) was found to be 0.92 and the intraclass correlation coefficient was 0.93. Patients with fibromyalgia, a very common central sensitivity syndrome (CSS), had the highest mean CSI-Turk scores, and healthy controls had the lowest. Using the recommended cut-off score of 40 resulted in 87% sensitivity and 90% specificity in distinguishing between fibromyalgia and control individuals.
This study suggests that the CSI-Turk can be effectively used as a screening tool to elucidate CS-related symptomology among patients with chronic pain with a high internal consistency, test-retest reliability, sensitivity, and specificity.</description><identifier>ISSN: 2148-5046</identifier><identifier>EISSN: 2618-6500</identifier><identifier>DOI: 10.46497/ArchRheumatol.2022.8665</identifier><identifier>PMID: 35382371</identifier><language>eng</language><publisher>Turkey: Turkish League Against Rheumatism</publisher><subject>Backache ; Care and treatment ; Fibromyalgia ; Medical research ; Medicine, Experimental ; Original ; Pain ; Translating and interpreting</subject><ispartof>Archives of rheumatology, 2021-12, Vol.36 (4), p.518-526</ispartof><rights>Copyright © 2021, Turkish League Against Rheumatism.</rights><rights>COPYRIGHT 2021 Turkish League Against Rheumatism</rights><rights>Copyright © 2021, Turkish League Against Rheumatism 2021 Turkish League Against Rheumatism</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2965-8f4a65d096638355becb71f60d36d6a9d5e900bb76bb84581df77204c3b645b83</citedby><cites>FETCH-LOGICAL-c2965-8f4a65d096638355becb71f60d36d6a9d5e900bb76bb84581df77204c3b645b83</cites><orcidid>0000-0002-0513-0619 ; 0000-0002-8600-9553 ; 0000-0002-1033-806X ; 0000-0002-8620-2468 ; 0000-0003-0294-4155 ; 0000-0002-8915-6970 ; 0000-0002-2910-2532 ; 0000-0002-1863-4453 ; 0000-0003-3165-7358</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957757/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957757/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35382371$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Düzce Keleş, Ela</creatorcontrib><creatorcontrib>Birtane, Murat</creatorcontrib><creatorcontrib>Ekuklu, Galip</creatorcontrib><creatorcontrib>Kılınçer, Cumhur</creatorcontrib><creatorcontrib>Çalıyurt, Okan</creatorcontrib><creatorcontrib>Taştekin, Nurettin</creatorcontrib><creatorcontrib>Is, Enes Efe</creatorcontrib><creatorcontrib>Ketenci, Ayşegül</creatorcontrib><creatorcontrib>Neblett, Randy</creatorcontrib><title>Validity and reliability of the Turkish version of the central sensitization inventory</title><title>Archives of rheumatology</title><addtitle>Arch Rheumatol</addtitle><description>The aim of this study was to translate the Central Sensitization Inventory (CSI) into the Turkish language, to perform a psychometric validation, and to investigate its reliability in patients with chronic spinal pain with an organic origin, patients with fibromyalgia, and pain-free control individuals.
Between April 2016 and February 2017, the translation of the original English version of the CSI into Turkish was performed using the forward-backward translation method. A total of 100 fibromyalgia patients (6 males, 94 females; mean age: 45.0±8.4 years; range, 25 to 60 years), 100 patients with chronic spinal pain with an identified organic origin (CSPO), (10 males, 90 females; mean age: 43.8±9.7 years; range, 21 to 60 years), and 100 healthy controls (8 males, 92 females; mean age: 35.8±10.1 years; range, 25 to 55 years) were included in the study. Demographic characteristics were collected. Test-retest reliability was determined by re-administering the CSI-Turkish (CSI-Turk) two weeks after the first application.
The internal consistency (Cronbach's alpha) was found to be 0.92 and the intraclass correlation coefficient was 0.93. Patients with fibromyalgia, a very common central sensitivity syndrome (CSS), had the highest mean CSI-Turk scores, and healthy controls had the lowest. Using the recommended cut-off score of 40 resulted in 87% sensitivity and 90% specificity in distinguishing between fibromyalgia and control individuals.
This study suggests that the CSI-Turk can be effectively used as a screening tool to elucidate CS-related symptomology among patients with chronic pain with a high internal consistency, test-retest reliability, sensitivity, and specificity.</description><subject>Backache</subject><subject>Care and treatment</subject><subject>Fibromyalgia</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Original</subject><subject>Pain</subject><subject>Translating and interpreting</subject><issn>2148-5046</issn><issn>2618-6500</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkV1LwzAUhoMobsz9BemVd51pk5ykN8IYfsFAkLnbkLTpGs3akXSD-ett3Rzu6ny_5xwehKIETyjQjN9PfV69V2a7Vm3jJilO04kAYBdomEIiYmAYX3Z-QkXMMIUBGofwiTFOKAfA5BoNCCMiJTwZouVSOVvYdh-puoi8cVZp6_q4KaO2MtFi679sqKKd8cE29V86N3XrlYuCqYNt7bdq-6Ktd12-8fsbdFUqF8z4aEfo4-lxMXuJ52_Pr7PpPM7TDFgsSqqAFTgDIIIwpk2ueVICLggUoLKCmQxjrTloLSgTSVFynmKaEw2UaUFG6OGgu9nqtSmOV8mNt2vl97JRVp5XalvJVbOTImOcM94J3B0EVsoZWRnl2io0btu_E-QUhMg4cNFvEofG3DcheFOeliRY_nKRZ1xkz0X2XLrR2_9Hngb_KJAfE_qPXw</recordid><startdate>202112</startdate><enddate>202112</enddate><creator>Düzce Keleş, Ela</creator><creator>Birtane, Murat</creator><creator>Ekuklu, Galip</creator><creator>Kılınçer, Cumhur</creator><creator>Çalıyurt, Okan</creator><creator>Taştekin, Nurettin</creator><creator>Is, Enes Efe</creator><creator>Ketenci, Ayşegül</creator><creator>Neblett, Randy</creator><general>Turkish League Against Rheumatism</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0513-0619</orcidid><orcidid>https://orcid.org/0000-0002-8600-9553</orcidid><orcidid>https://orcid.org/0000-0002-1033-806X</orcidid><orcidid>https://orcid.org/0000-0002-8620-2468</orcidid><orcidid>https://orcid.org/0000-0003-0294-4155</orcidid><orcidid>https://orcid.org/0000-0002-8915-6970</orcidid><orcidid>https://orcid.org/0000-0002-2910-2532</orcidid><orcidid>https://orcid.org/0000-0002-1863-4453</orcidid><orcidid>https://orcid.org/0000-0003-3165-7358</orcidid></search><sort><creationdate>202112</creationdate><title>Validity and reliability of the Turkish version of the central sensitization inventory</title><author>Düzce Keleş, Ela ; Birtane, Murat ; Ekuklu, Galip ; Kılınçer, Cumhur ; Çalıyurt, Okan ; Taştekin, Nurettin ; Is, Enes Efe ; Ketenci, Ayşegül ; Neblett, Randy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2965-8f4a65d096638355becb71f60d36d6a9d5e900bb76bb84581df77204c3b645b83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Backache</topic><topic>Care and treatment</topic><topic>Fibromyalgia</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Original</topic><topic>Pain</topic><topic>Translating and interpreting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Düzce Keleş, Ela</creatorcontrib><creatorcontrib>Birtane, Murat</creatorcontrib><creatorcontrib>Ekuklu, Galip</creatorcontrib><creatorcontrib>Kılınçer, Cumhur</creatorcontrib><creatorcontrib>Çalıyurt, Okan</creatorcontrib><creatorcontrib>Taştekin, Nurettin</creatorcontrib><creatorcontrib>Is, Enes Efe</creatorcontrib><creatorcontrib>Ketenci, Ayşegül</creatorcontrib><creatorcontrib>Neblett, Randy</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Archives of rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Düzce Keleş, Ela</au><au>Birtane, Murat</au><au>Ekuklu, Galip</au><au>Kılınçer, Cumhur</au><au>Çalıyurt, Okan</au><au>Taştekin, Nurettin</au><au>Is, Enes Efe</au><au>Ketenci, Ayşegül</au><au>Neblett, Randy</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Validity and reliability of the Turkish version of the central sensitization inventory</atitle><jtitle>Archives of rheumatology</jtitle><addtitle>Arch Rheumatol</addtitle><date>2021-12</date><risdate>2021</risdate><volume>36</volume><issue>4</issue><spage>518</spage><epage>526</epage><pages>518-526</pages><issn>2148-5046</issn><eissn>2618-6500</eissn><abstract>The aim of this study was to translate the Central Sensitization Inventory (CSI) into the Turkish language, to perform a psychometric validation, and to investigate its reliability in patients with chronic spinal pain with an organic origin, patients with fibromyalgia, and pain-free control individuals.
Between April 2016 and February 2017, the translation of the original English version of the CSI into Turkish was performed using the forward-backward translation method. A total of 100 fibromyalgia patients (6 males, 94 females; mean age: 45.0±8.4 years; range, 25 to 60 years), 100 patients with chronic spinal pain with an identified organic origin (CSPO), (10 males, 90 females; mean age: 43.8±9.7 years; range, 21 to 60 years), and 100 healthy controls (8 males, 92 females; mean age: 35.8±10.1 years; range, 25 to 55 years) were included in the study. Demographic characteristics were collected. Test-retest reliability was determined by re-administering the CSI-Turkish (CSI-Turk) two weeks after the first application.
The internal consistency (Cronbach's alpha) was found to be 0.92 and the intraclass correlation coefficient was 0.93. Patients with fibromyalgia, a very common central sensitivity syndrome (CSS), had the highest mean CSI-Turk scores, and healthy controls had the lowest. Using the recommended cut-off score of 40 resulted in 87% sensitivity and 90% specificity in distinguishing between fibromyalgia and control individuals.
This study suggests that the CSI-Turk can be effectively used as a screening tool to elucidate CS-related symptomology among patients with chronic pain with a high internal consistency, test-retest reliability, sensitivity, and specificity.</abstract><cop>Turkey</cop><pub>Turkish League Against Rheumatism</pub><pmid>35382371</pmid><doi>10.46497/ArchRheumatol.2022.8665</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-0513-0619</orcidid><orcidid>https://orcid.org/0000-0002-8600-9553</orcidid><orcidid>https://orcid.org/0000-0002-1033-806X</orcidid><orcidid>https://orcid.org/0000-0002-8620-2468</orcidid><orcidid>https://orcid.org/0000-0003-0294-4155</orcidid><orcidid>https://orcid.org/0000-0002-8915-6970</orcidid><orcidid>https://orcid.org/0000-0002-2910-2532</orcidid><orcidid>https://orcid.org/0000-0002-1863-4453</orcidid><orcidid>https://orcid.org/0000-0003-3165-7358</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2148-5046 |
ispartof | Archives of rheumatology, 2021-12, Vol.36 (4), p.518-526 |
issn | 2148-5046 2618-6500 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8957757 |
source | EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
subjects | Backache Care and treatment Fibromyalgia Medical research Medicine, Experimental Original Pain Translating and interpreting |
title | Validity and reliability of the Turkish version of the central sensitization inventory |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T19%3A29%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Validity%20and%20reliability%20of%20the%20Turkish%20version%20of%20the%20central%20sensitization%20inventory&rft.jtitle=Archives%20of%20rheumatology&rft.au=D%C3%BCzce%20Kele%C5%9F,%20Ela&rft.date=2021-12&rft.volume=36&rft.issue=4&rft.spage=518&rft.epage=526&rft.pages=518-526&rft.issn=2148-5046&rft.eissn=2618-6500&rft_id=info:doi/10.46497/ArchRheumatol.2022.8665&rft_dat=%3Cgale_pubme%3EA688976788%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/35382371&rft_galeid=A688976788&rfr_iscdi=true |